Hims & Hers Health (HIMS) Cost of Revenue (2020 - 2026)
Hims & Hers Health's Cost of Revenue history spans 7 years, with the latest figure at $222.0 million for Q1 2026.
- On a quarterly basis, Cost of Revenue fell 3.99% to $222.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $910.1 million, a 5.7% increase, with the full-year FY2025 number at $919.3 million, up 35.42% from a year prior.
- Cost of Revenue hit $222.0 million in Q1 2026 for Hims & Hers Health, down from $238.0 million in the prior quarter.
- Over the last five years, Cost of Revenue for HIMS hit a ceiling of $487.1 million in Q4 2024 and a floor of $26.4 million in Q2 2022.
- Historically, Cost of Revenue has averaged $147.6 million across 5 years, with a median of $83.7 million in 2024.
- Biggest five-year swings in Cost of Revenue: tumbled 61.74% in 2022 and later skyrocketed 852.06% in 2023.
- Tracing HIMS's Cost of Revenue over 5 years: stood at $34.9 million in 2022, then skyrocketed by 852.06% to $331.9 million in 2023, then soared by 46.73% to $487.1 million in 2024, then tumbled by 51.13% to $238.0 million in 2025, then decreased by 6.74% to $222.0 million in 2026.
- Business Quant data shows Cost of Revenue for HIMS at $222.0 million in Q1 2026, $238.0 million in Q4 2025, and $232.2 million in Q3 2025.